OBJECTIVE -To determine random capillary blood glucose (RCBG) cut points that discriminate diabetic and pre-diabetic subjects from normal individuals.
A pproximately 50 -70% of people with diabetes remain undiagnosed in both developed (1) and developing countries (2), and these individuals often present with diabetes complications (3). It is established that good control of diabetes can prevent complications. Undiagnosed diabetes and pre-diabetes therefore need to be detected and treated early through community-based screening (4).
Definitions of diabetes are usually based on fasting or postprandial glucose. However, random capillary blood glucose (RCBG) is the most convenient way to reach large numbers of people. A few studies in Western countries (5, 6 ) have tried to correlate RCBG with 2-h plasma glucose or fasting plasma glucose (FPG) (the basis for the World Health Organization [WHO] and American Diabetes Association [ADA] definitions) but none from India, which has the largest number of people with diabetes globally (7) . There are also no data on RCBG cut points for pre-diabetes states such as impaired fasting glucose (IFG) and impaired glucose tolerance (IGT). This is particularly relevant because IFG now has two definitions: Ն100 mg/dl (5.6 mmol/l) according to ADA (8) and Ն110 mg/dl (6.1 mmol/l) according to WHO (9) .
The aim of this study, carried out in a community setting in southern India, was to derive RCBG cut points that discriminate diabetic from nondiabetic and pre-diabetic from non-pre-diabetic individuals. (10) .
RESEARCH DESIGN AND METHODS
Individuals with self-reported diabetes (n ϭ 13,340) were excluded. Of the remaining 63,305 subjects, 1,500 individuals were randomly selected and invited to attend Dr. Mohan's Diabetes Specialities Centre, a tertiary referral center for diabetes care, to undergo an oral glucose tolerance test within the next 2 to 3 days. A total of 1,333 individuals responded to the invitation (88.9% response rate). A sample was drawn for FPG estimation, 75 g of oral glucose was given, and a second sample was drawn at 120 min (2-h plasma glucose).
Statistical analysis
Statistical analysis was performed using SPSS for PC Windows, version 10.0 (SPSS, Chicago, IL). Receiver operating characteristic curves were plotted using sensitivity and 1-specificity for different cutoff values of RCBG. Using the receiver operating characteristic technique, comparison of sensitivity with specificity was made over the entire range of RCBG cut points, and areas under the curve were plotted. By interpolation from the area under the curve, the point closest to the upper-left corner, which maximized sensitivity and specificity, was selected; this identified the highest number of subjects with or without a diabetes condition (11) . In this manner, RCBG cut points were determined for diabetes, IGT, and IFG using ADA (8) and WHO (9) criteria (supplemental Figure 1A , available in an online appendix at http://care.diabetesjournals. org/cgi/content/full/dc08-0403/DC1).
RESULTS -For the study group, mean Ϯ SD age was 45.5 Ϯ 10.7 years, BMI was 24.8 Ϯ 4.0 kg/m 2 , and 45.2% were men. Additionally, 27.2% (n ϭ 363) had RCBG Ͻ100 mg/dl (5.6 mmol/l), 65.9% (n ϭ 878) had RCBG in the range of 100 -200 mg/dl (5.6 -11.1 mmol/l), and 6.9% (n ϭ 92) had RCBG Ͼ200 mg/dl (11.1 mmol/l).
Using the 2-h plasma glucose Ն200 mg/dl (11.1 mmol/l) criterion, the RCBG cut point of 140 mg/dl (7.7 mmol/l) gave the highest sensitivity and specificity (Table 1). Using the 2-h plasma glucose Ն200 mg/dl (11.1 mmol/l) and FPG Ն126 mg/dl (7.0 mmol/l) criteria, either 2-h plasma glucose Ն200 mg/dl (11.1 mmol/l) or FPG Ն126 mg/dl (7.0 mmol/l) criterion, or for FPG Ն126 mg/dl (7.0 mmol/l) criterion, the RCBG cut point was 143 mg/dl (7.9 mmol/l).
For IGT, the RCBG cut point was 119 mg/dl (6.6 mmol/l). Using the IFG (WHO) criterion of FPG Ն110 (6.1 mmol/l) and Ͻ126 mg/dl (7.0 mmol/l), the RCBG cut point was 118 mg/dl (6.6 mmol/l), while for the IFG (ADA) criterion of FPG Ն100 mg/dl (5.6 mmol/l) and Ͻ126 mg/dl (7.0 mmol/l), the RCBG cut point was 113 mg/dl (6.3 mmol/l).
CONCLUSIONS -The most commonly used tests for screening for type 2 diabetes are FPG and 2-h plasma glucose (9, 10) . Measurement of RCBG has an advantage in that it can be undertaken at any time of the day, does not require a venipuncture, and can even be performed by laypeople. In studies from North America, RCBG cut points ranging from 99 to 140 mg/dl have been reported to identify diabetes (5, (12) (13) (14) .
Our study presents the first such data from India and shows that, in Asian Indians, RCBG cut points of 140 and 143 mg/dl (7.8 and 7.9 mmol/l) maximized the sensitivity and specificity for diabetes. Moreover, this study provides the first data, to our knowledge, on RCPG cut points for IGT (119 mg/dl [6.6 mmol/l]), two definitions of IFG (WHO 118 mg/dl and ADA 113 mg/dl), and abnormal glucose tolerance (141 mg/dl) and regulation (121 mg/dl).
The strengths of this study are that it is based on a large number of subjects, was performed in a "real life" communitybased setting, and is the first, to our knowledge, to report on cut points for IGT and IFG according to WHO and ADA criteria.
Based on the findings of our study, we propose that in opportunistic screening studies in Asian Indians, all those with RCBG values Ͼ110 mg/dl (6.1 mmol/l) should receive more definitive tests for diabetes and pre-diabetes. This could not only help limit the number of individuals who must arrive for screening in a fasting state but also reduce the costs of screening, as only 60% of those screened would have RCBG Ͼ110 mg/dl. 
